Studies using neurohormonal antagonists drugs such as Angiotensin-converting enzyme (ACE) inhibitors or Angiotensin receptor blockers (ARB), beta-blockers, and others have been successful or unsuccessful in preventing doxorubicin-induced cardiomyopathy. Here, ACE is linked to cardiomyopathy.